A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010008/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare overall survival in newly diagnosed metastatic
prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700
versus ADT + bicalutamide.
提供机构：
Vivli
创建时间：
2024-04-11
